75 related articles for article (PubMed ID: 18680516)
1. No association of the CD45 77C>G transversion with inflammatory bowel disease in German patients.
Thude H; Rebstock K; Blume J; Lutz B; Barz D
Int J Immunogenet; 2008 Aug; 35(4-5):335-7. PubMed ID: 18680516
[TBL] [Abstract][Full Text] [Related]
2. No association between transmembrane protein-tyrosine-phosphatase receptor type C (CD45) exon A 77C>G transversion and Hashimoto's thyroiditis in a German population.
Thude H; Weissenborn S; Vilser C; Müller UA; Kloos C; Wolf G; Beck J; Barz D
Hum Immunol; 2010 Feb; 71(2):220-3. PubMed ID: 19879912
[TBL] [Abstract][Full Text] [Related]
3. No association between transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77C>G) and idiopathic dilated cardiomyopathy.
Thude H; Gerlach K; Richartz B; Krack A; Brenke B; Pethig K; Figulla HR; Barz D
Hum Immunol; 2005 Sep; 66(9):1008-12. PubMed ID: 16360841
[TBL] [Abstract][Full Text] [Related]
4. A transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77 C to G) is not associated with the development of type 1 diabetes mellitus in a German population.
Thude H; Rosenhahn S; Hunger-Dathe W; Müller UA; Barz D
Eur J Immunogenet; 2004 Dec; 31(6):245-7. PubMed ID: 15548260
[TBL] [Abstract][Full Text] [Related]
5. Enhanced frequency of a PTPRC (CD45) exon A mutation (77C-->G) in systemic sclerosis.
Schwinzer R; Witte T; Hundrieser J; Ehlers S; Momot T; Hunzelmann N; Krieg T; Schmidt RE; Wonigeit K
Genes Immun; 2003 Mar; 4(2):168-9. PubMed ID: 12618866
[TBL] [Abstract][Full Text] [Related]
6. Does 77C-->G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus?
Vorechovsky I; Kralovicova J; Tchilian E; Masterman T; Zhang Z; Ferry B; Misbah S; Chapel H; Webster D; Hellgren D; Anvret M; Hillert J; Hammarstrom L; Beverley PC
Nat Genet; 2001 Sep; 29(1):22-3. PubMed ID: 11548742
[TBL] [Abstract][Full Text] [Related]
7. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between expression of inhibitory killer cell immunoglobulin-like receptor HLA-Cw ligand and susceptibility to inflammatory bowel disease].
Zhang HX; Li JC; Liu ZJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3108-11. PubMed ID: 19159590
[TBL] [Abstract][Full Text] [Related]
9. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
[TBL] [Abstract][Full Text] [Related]
10. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 10 promoter region polymorphisms in inflammatory bowel disease in Tunisian population.
Marrakchi R; Moussa A; Ouerhani S; Bougatef K; Bouhaha R; Messai Y; Rouissi K; Khadimallah I; Khodjet-el-Khil H; Najar T; Benammar-Elgaaeid A
Inflamm Res; 2009 Mar; 58(3):155-60. PubMed ID: 19184348
[TBL] [Abstract][Full Text] [Related]
12. Nuclear pregnane X receptor single nucleotide polymorphism (-25385C/T) is not associated with inflammatory bowel disease in pediatric patients.
Lacher M; Kappler R; Schroepf S; Berkholz S; Ballauff A; Bufler P; Baurecht H; von Schweinitz D; Koletzko S
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):147-50. PubMed ID: 19516190
[TBL] [Abstract][Full Text] [Related]
13. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
14. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population.
Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P
Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269
[TBL] [Abstract][Full Text] [Related]
15. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of alpha- and beta-defensins in plasma of patients with inflammatory bowel disease.
Yamaguchi N; Isomoto H; Mukae H; Ishimoto H; Ohnita K; Shikuwa S; Mizuta Y; Nakazato M; Kohno S
Inflamm Res; 2009 Apr; 58(4):192-7. PubMed ID: 19184352
[TBL] [Abstract][Full Text] [Related]
17. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
Glas J; Seiderer J; Pasciuto G; Tillack C; Diegelmann J; Pfennig S; Konrad A; Schmechel S; Wetzke M; Török HP; Stallhofer J; Jürgens M; Griga T; Klein W; Epplen JT; Schiemann U; Mussack T; Lohse P; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Mar; 104(3):665-72. PubMed ID: 19262523
[TBL] [Abstract][Full Text] [Related]
18. No association between transmembrane protein-tyrosine phosphatase receptor type C (PTPRC) exon A 77C>G transversion and liver transplant rejection.
Thude H; Schipler AD; Treszl A; Sterneck M; Nashan B
Int J Immunogenet; 2012 Oct; 39(5):437-41. PubMed ID: 22524693
[TBL] [Abstract][Full Text] [Related]
19. An update on the epidemiology of inflammatory bowel disease in Asia.
Thia KT; Loftus EV; Sandborn WJ; Yang SK
Am J Gastroenterol; 2008 Dec; 103(12):3167-82. PubMed ID: 19086963
[TBL] [Abstract][Full Text] [Related]
20. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP
Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
